|
441 |
SEBI queries Sun on Ranbaxy deal |
Download (34.12 KB)  |
11/04/2014 |
|
442 |
Sun Pharmas behind-the -scenes chief |
Download (88.82 KB) |
11/04/2014 |
|
443 |
SEBI to proble share movements in Ranbaxy |
Download (54.67 KB) |
10/04/2014 |
|
444 |
Sun pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S. |
Download (27.28 KB) |
10/04/2014 |
|
445 |
EU exports to remain suspended |
Download (59.34 KB) |
10/04/2014 |
|
446 |
Sun Pharma denies insider trading charges in Ranbaxy deal |
Download (66.72 KB) |
10/04/2014 |
|
447 |
Ranbaxy brand phaseout likely |
Download (25.17 KB) |
10/04/2014 |
|
448 |
Will cancel Ranbaxy stock taken by Silverstreet once it is issued |
Download (105.42 KB) |
10/04/2014 |
|
449 |
US approvals key to Glenmarks prospects |
Download (92.48 KB) |
10/04/2014 |
|
450 |
We are going to retain Ranbaxy brand wherever it is strong |
Download (74.67 KB) |
10/04/2014 |
|
451 |
Zydus to have 15 biologic products |
Download (19.95 KB) |
10/04/2014 |
|
452 |
Sun Pharma to face challenges in rectifying quality control |
Download (87.11 KB) |
09/04/2014 |
|
453 |
From a drug distributor to global pharma tycoon |
Download (51.44 KB) |
08/04/2014 |
|
454 |
Aurobindo acquires actavis |
Download (18.39 KB) |
02/04/2014 |
|
455 |
Natco set for US launch of generic copy of Tevas drugg |
Download (38.25 KB) |
02/04/2014 |
|
456 |
GSK to invest $216m in African markets |
Download (76.94 KB) |
02/04/2014 |
|
457 |
Novartis heart drug trial successful |
Download (27.4 KB) |
01/04/2014 |
|
458 |
Dr. Reddys eyes fresh foray into Japanese market |
Download (58.58 KB) |
31/03/2014 |
|
459 |
Overweight on Lupin, target Rs. 1,084 |
Download (30.4 KB) |
29/03/2014 |
|
460 |
Dr. Reddys capacity expansion |
Download (17.78 KB) |
29/03/2014 |
औषध विभाग
Department of
